Healthcare is the anchor for US economic growth in these challenging times, and THQ pays big monthly distributions to enjoy ...
Massachusetts biotech Replimune laid off more than 200 employees Friday after the Food and Drug Administration doubled down ...
From the Capital of France to the Capital of New York -- a cutting-edge biotech firm that uses AI to research cancer ...
The incubator will be known as RoVa Labs at Carilion Clinic and will support the growth of research spinoffs and start-up ...
The U.S. Chamber of Commerce conducted a nationwide media tour featuring Brad Watts, Senior Vice President of the Global Innovation Policy Center, to spotlight the extraordinary human and economic ...
French biotech firm One Biosciences, which uses artificial intelligence to develop personalized cancer treatments, is setting ...
Eli Lilly, the maker of the popular GLP-1 injectable Mounjaro, has invested heavily in Houston as a biotechnology hub.
San Antonio Mayor Gina Ortiz Jones ruffles feathers trying to boost the economy and strike the best deal for residents.
The trend of fewer companies letting employees go, which began in the fourth quarter of last year, has continued. However, ...
For decades, America has led the global biotech industry – thanks, in part, to state-level policies that encourage research and manufacturing investments.
After receiving a drug rejection from the FDA, Woburn-based Replimune Group (Nasdaq: REPL) has informed the state that it ...
LifeSciencesNY, a trade group based in Central New York, urges state legislators to fund this effort in the upcoming state ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results